No Comments

Hikma Ventures Leads ‘Series A Financing For Development Of Winterlight Labs AI Vocal Technology To Detect Central Nervous System Disorders And Track Efficacy Of Treatments

Image for Hikma Ventures Leads ‘Series A Financing For Development Of Winterlight Labs AI Vocal Technology To Detect Central Nervous System Disorders And Track Efficacy Of Treatments

Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY),, the multinational pharmaceutical company, announced that its venture capital

Read More

Cyber Gear Webinar Series